Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 1 - 20 out of 500 displayed.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »
Reset ↻

Foresee Pharmaceuticals to Present Phase 1/2 Fanconi Anemia Clinical Study Design for its ALDH2 activator FP-045 at the Fanconi Anemia Research Fund 2023 Scientific Symposium

By: PR Newswire Association LLC. - 30 Sep 2023

Related companies: Foresee Pharmaceuticals Co., Ltd.

Rising Healthcare Expenditure and Aging Population Drive Demand for Vascular Grafts Globally

By: PR Newswire Association LLC. - 30 Sep 2023

Cardiovascular Crisis Meets Cutting-Edge Solutions: Insights from the Peripheral Vascular Stents Market Report

By: PR Newswire Association LLC. - 30 Sep 2023

SmileDirectClub Seeks to Execute Comprehensive Recapitalization to Strengthen the Business for Sustainable Growth

By: GlobeNewswire - 30 Sep 2023

Related companies: SmileDirectClub, Inc.

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Unveil Wide Range of Innovative Radiation Oncology Research at the 2023 ASTRO Annual Meeting

By: PR Newswire Association LLC. - 30 Sep 2023

MicroRNA (miRNA) Market size to grow by USD 2.02 billion from 2022-2027| BioGenex Laboratories Inc., BioVendor Laboratorni medicina AS, GeneCopoeia Inc., and more among the market key players - Technavio

By: PR Newswire Association LLC. - 30 Sep 2023

FDA Grants First Marketing Authorization for a DNA Test to Assess Predisposition for Dozens of Cancer Types

By: PR Newswire Association LLC. - 30 Sep 2023

Related companies: U.S. Food and Drug Administration

Organic and Chemical-free Products Fueling the Global Hair Growth Supplements Market

By: PR Newswire Association LLC. - 30 Sep 2023

Real-World Evidence and Data Analytics Conference (Frankfurt, Germany - October 5-6, 2023): Paving the Path for Next-Gen Medicinal Research

By: PR Newswire Association LLC. - 30 Sep 2023

North America Dominates the Image Guided Surgery Devices Market with a Strong CAGR of 3.5%, Emerging Economies Show Strong Growth Potential

By: PR Newswire Association LLC. - 30 Sep 2023

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

By: GlobeNewswire - 29 Sep 2023

Related companies: Spero Therapeutics, Inc.

FDA Approves Biogen’s TOFIDENCE™ (tocilizumab-bavi), a Biosimilar Referencing ACTEMRA®

By: GlobeNewswire - 29 Sep 2023

Related companies: Biogen Inc.

NANOBIOTIX Announces Oral Presentation of Final Results From a Phase 1 Dose Expansion Study Evaluating NBTXR3 in Head and Neck Cancer at the 65th Annual Meeting of the American Society for Radiation Oncology

By: GlobeNewswire - 29 Sep 2023

Related companies: Nanobiotix SA | Nanoco Technologies Ltd.

Interim results for the six months ended 30 June 2023

By: GlobeNewswire - 29 Sep 2023

Related companies: Biodexa Pharmaceuticals PLC

Vision Sensing Acquisition Corp. Announces Intention to Extend Period to Consummate Initial Business Combination to November 3, 2023

By: GlobeNewswire - 29 Sep 2023

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

By: GlobeNewswire - 29 Sep 2023

Related companies: Cidara Therapeutics, Inc.

KVK-Tech, Inc. Issues Voluntary Nationwide Recall of one lot of Betaxolol Tablets, USP 10 mg (Batch Number: 17853A) as a precautionary measure due to a single foreign tablet found during the line clearance after the batch was packaged

By: PR Newswire Association LLC. - 29 Sep 2023

Related companies: KVK Tech, Inc.

Global Call to Action on Sleep Health Published in The Lancet Public Health

By: PR Newswire Association LLC. - 29 Sep 2023

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

By: PR Newswire Association LLC. - 29 Sep 2023

Syndax to Announce Topline Results from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia and Host an Investor Call on October 2, 2023

By: PR Newswire Association LLC. - 29 Sep 2023

Related companies: Syndax Pharmaceuticals, Inc.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

Home Page

News in the Life Sciences Industry